2020
DOI: 10.1101/2020.02.07.938753
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres

Abstract: Telomeres consist of TTAGGG repeats bound by protein complexes that serve to protect the natural end of linear chromosomes. Most cells maintain telomere repeat lengths by utilizing the enzyme telomerase, although there are some cancer cells that use a telomerase-independent mechanism of telomere extension, termed Alternative Lengthening of Telomeres (ALT). Cells that employ ALT are characterized, in part, by the presence of specialized PML nuclear bodies called ALT-associated PML-Bodies (APBs). APBs localize t… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
29
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(34 citation statements)
references
References 70 publications
5
29
0
Order By: Relevance
“…A key difference is that U2OS cells maintain their telomeres via a recombination‐based replication process called alternative lengthening of telomeres (ALT), as they do not have active telomerase (Bryan et al , 1997; Cesare & Reddel, 2010). ALT telomeres undergo DNA synthesis in the G2/M phases of the cell cycle at ALT‐associated PML bodies (APBs) that contain PCNA among other DNA replication and repair factors (Dilley et al , 2016; Min et al , 2017; Pan et al , 2017; Zhang et al , 2019; Sobinoff & Pickett, 2020; Loe et al , 2020). Further analysis revealed that the atypical FAM111A foci in U2OS cells colocalize with both PCNA and PML (Fig 1C).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…A key difference is that U2OS cells maintain their telomeres via a recombination‐based replication process called alternative lengthening of telomeres (ALT), as they do not have active telomerase (Bryan et al , 1997; Cesare & Reddel, 2010). ALT telomeres undergo DNA synthesis in the G2/M phases of the cell cycle at ALT‐associated PML bodies (APBs) that contain PCNA among other DNA replication and repair factors (Dilley et al , 2016; Min et al , 2017; Pan et al , 2017; Zhang et al , 2019; Sobinoff & Pickett, 2020; Loe et al , 2020). Further analysis revealed that the atypical FAM111A foci in U2OS cells colocalize with both PCNA and PML (Fig 1C).…”
Section: Resultsmentioning
confidence: 99%
“…Human embryonic kidney cell lines HEK293 and HEK293T, human osteosarcoma cell line U2OS, human colon cancer line HCT116, and human cervical adenocarcinoma cell line HeLa were obtained from American Type Culture Collection (ATCC). Human epithelial cells immortalized with hTERT cell line RPE was obtained from Denchi lab (Loe et al , 2020). These cell lines were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS).…”
Section: Methodsmentioning
confidence: 99%
“…A recent study suggests that the formation of APBs is driven by phase separation, thus promoting the clustering of telomere repeats and telomere lengthening ( Zhang et al, 2020 ; Figure 6 ). Consequently, knocking down the PML body component PML inhibited APB formation and caused telomere shortening ( Draskovic et al, 2009 ; Loe et al, 2020 ; Osterwald et al, 2015 ). Together, this suggests that APBs facilitate ALT telomere maintenance, eventually allowing cancer cells to grow indefinitely and become immortal.…”
Section: Introductionmentioning
confidence: 99%
“…APP-CT was either uniformly distributed or concentrated at the inner wall of the nuclear body (Figure 2L). These results suggest that upon translocation of APP-CT into the nucleus, there is a regulated interaction between the APP-CT/FE65/TIP60 complex, p53 and PML bodies 40 .…”
Section: Resultsmentioning
confidence: 80%